An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation.

IF 1.9 4区医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

Journal of Interferon and Cytokine Research Pub Date : 2024-09-01 Epub Date: 2024-07-01 DOI:10.1089/jir.2024.0099

Tahmineh Safaie, Kham R Trinh, Alex Vasuthasawat, Sherie L Morrison, David R Stover

引用次数: 0

查看原文本刊更多论文

抗CD138靶向干扰素-α通过直接杀伤肿瘤细胞和瘤内免疫调节对实体瘤具有广泛疗效

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Interferon and Cytokine Research 医学-免疫学

CiteScore

3.80

自引率

0.00%

发文量

审稿时长

2.2 months

期刊介绍： Journal of Interferon & Cytokine Research (JICR) provides the latest groundbreaking research on all aspects of IFNs and cytokines. The Journal delivers current findings on emerging topics in this niche community, including the role of IFNs in the therapy of diseases such as multiple sclerosis, the understanding of the third class of IFNs, and the identification and function of IFN-inducible genes.